Clinical Trials Logo

Graft Loss clinical trials

View clinical trials related to Graft Loss.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04367610 Completed - Clinical trials for Kidney Transplant Rejection

Effects of A Standardized Treatment Approach on Kidney Transplant Recipients With Antibody-Mediated Rejection

Start date: September 1, 2019
Phase:
Study type: Observational

Antibody-mediated rejection (ABMR) is one of the leading causes of graft loss in kidney transplant recipients (KTRs). Although it is a well characterized entity, there is limited data regarding effective treatment options for preserving graft functions. Moreover, results from different studies have been contradictory. Therefore, we conducted a study using our registry data to evaluate the effects of a standardized treatment approach consisting of therapeutic plasma exchange (regular plasmapheresis, double filtration plasmapheresis or immunoadsorption), intravenous immunoglobulin and rituximab on KTRs with acute or chronic ABMR.

NCT ID: NCT03412838 Completed - Graft Loss Clinical Trials

Factors Influencing Bone Block Allograft Resorption

Start date: January 2011
Phase: N/A
Study type: Interventional

A main drawback of bone block graft surgery is the resorption occurring in early stages of healing. The aim of this work was investigate different factors associated with graft resorption in allogeneic bone block graft surgery.

NCT ID: NCT02387151 Completed - Rejection Clinical Trials

Allogeneic Mesenchymal Stromal Cell Therapy in Renal Transplant Recipients

Neptune
Start date: March 2015
Phase: Phase 1
Study type: Interventional

This study will test whether selected allogeneic bone marrow derived MSCs are safe by assessing the composite end point Biopsy Proven Acute Rejection (BPAR)/ graft loss at 12 months.